Expanded Access to Tipifarnib

Summary

Requests for single patient expanded access to tipifarnib may be considered for adult patients with HRAS mutations or peripheral T Cell Lymphoma (PTCL). To request access, use Responsible Party contact information provided in this record. Expanded access for tipifarnib is only available in the United States.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications